logo
Select company
Select metric
Ticker Information

Ticker

PROK

Company Name

PROKIDNEY CORP

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

PROKIDNEY CORP - Return on Equity Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

PROK - ROE Historical data
DateShareholders EquityNet Income Common StockReturn on Equity
6/30/2025$ -1B$ -72.47M0%
3/31/2025$ -998.55M$ -68.43M0%
12/31/2024$ -994.95M$ -61.19M0%
9/30/2024$ -979.71M$ -45.61M0%
6/30/2024$ -972.37M$ -38.68M0%
3/31/2024$ -1.1B$ -35.3M0%
12/31/2023$ -1.1B$ -35.47M0%
9/30/2023$ -1.09B$ -36.25M0%
6/30/2023$ -1.32B$ -37.2M0%
3/31/2023$ -1.6B$ -30.35M0%
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • PROKIDNEY CORP's latest trailing twelve months (TTM) ROE stands at 0%.
  • Over the past 5 years, PROKIDNEY CORP's average ROE has been -1411.25%.
  • The median ROE for PROKIDNEY CORP during this period was -1411.25%
  • PROKIDNEY CORP reached its highest ROE over the past 5 years at -608.06%.
  • The lowest ROE recorded by PROKIDNEY CORP in the same timeframe -2214.44%

PROKIDNEY CORP's ROE vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

ROE Benchmarks
CompanyROE
SEPN : SEPTERNA INC -23.18%MREO : MEREO BIOPHARMA GROUP PLC -91.46%ABEO : ABEONA THERAPEUTICS INC 34.99%CRDF : CARDIFF ONCOLOGY INC -87.1%AVTX : AVALO THERAPEUTICS INC -44.19%BBOT : BRIDGEBIO ONCOLOGY THERAPEUTICS INC -COYA : COYA THERAPEUTICS INC -71.84%MNMD : MIND MEDICINE (MINDMED) INC -61.77%SANA : SANA BIOTECHNOLOGY INC -205.77%ERNA : ERNEXA THERAPEUTICS INC -983.8%

Definition of Return on Equity

[Calculation] Return on Equity (ROE) measures net income [NetIncCmn] as percentage of [Equity]. A high ROE shows an effective use of investor capital, but it doesn't consider any risks related to financial leverage [Debt].
Net Inc. Cmn. / Equity
(=) ROE
ROE for PROKIDNEY CORP is calculated as follows: Net Inc. Cmn. [ $ 0 ] / Equity [ $ 19.82K ]
(=) ROE [ 0% ]

PROK - Return on Equity, Last 5 years

-2214.44%

Minimum

Jun 30, 2022

-608.06%

Maximum

Mar 31, 2022

-1411.25%

Average

-1411.25%

Median

ROE Benchmark Analysis

The chart above depicts the distribution of ROE for companies in the Total Stock Market. The average ROE of the companies is 1.51% with a standard deviation of 22.68%.
The following table provides additional summary stats:
ROE in the Market:
filtered constituents3.14K
min-66.79%
max73.25%
average1.51%
median6.45%
std22.68%